Suppr超能文献

对阿米卡星和异帕米星具有更高活性的突变 APH(2'')-IIa 酶。

Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.

机构信息

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.

出版信息

Antimicrob Agents Chemother. 2010 Apr;54(4):1590-5. doi: 10.1128/AAC.01444-09. Epub 2010 Feb 9.

Abstract

Directed evolution by random PCR mutagenesis of the gene for the aminoglycoside 2''-IIa phosphotransferase generated R92H/D268N and N196D/D268N mutant enzymes, resulting in elevated levels of resistance to amikacin and isepamicin but not to other aminoglycoside antibiotics. Increases in the activities of the mutant phosphotransferases for isepamicin are the result of decreases in K(m) values, while improved catalytic efficiency for amikacin is the result of both a decrease in K(m) values and an increase in turnover of the antibiotic. Enzymes with R92H, D268N, and D268N single amino acid substitutions did not result in elevated MICs for aminoglycosides.

摘要

通过随机 PCR 诱变对氨基糖苷 2''-IIa 磷酸转移酶基因进行定向进化,产生了 R92H/D268N 和 N196D/D268N 突变酶,导致对阿米卡星和异帕米星的耐药水平升高,但对其他氨基糖苷类抗生素没有影响。突变磷酸转移酶对异帕米星的活性增加是由于 K(m) 值降低所致,而对阿米卡星的催化效率提高则是由于 K(m) 值降低和抗生素周转率增加所致。具有 R92H、D268N 和 D268N 单个氨基酸取代的酶不会导致氨基糖苷类药物 MIC 值升高。

相似文献

引用本文的文献

本文引用的文献

3
Do we still need the aminoglycosides?我们仍然需要氨基糖苷类药物吗?
Int J Antimicrob Agents. 2009 Mar;33(3):201-5. doi: 10.1016/j.ijantimicag.2008.09.001. Epub 2008 Oct 30.
4
Emergence and management of drug-resistant enterococcal infections.耐药肠球菌感染的出现与管理
Expert Rev Anti Infect Ther. 2008 Oct;6(5):637-55. doi: 10.1586/14787210.6.5.637.
5
Aminoglycoside 2''-phosphotransferase type IIIa from Enterococcus.来自肠球菌的IIIa型氨基糖苷2''-磷酸转移酶
J Biol Chem. 2008 Mar 21;283(12):7638-47. doi: 10.1074/jbc.M709645200. Epub 2008 Jan 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验